 |
|
|
|
Events supported by partneringONE®
partneringONE® has established itself as the most
relied upon service for world-class conference partnering.
Our list of references from collaborators using partneringONE
to enhance their events and ensure success continues to
grow. Year after year.
EBD Group provides partnering services for the following events:
| |
 |
February 1–2, 2012
La Jolla, CA, USA |
BIOCOM’s second annual Global Life Science Partnering Conference is an exclusive global partnering and networking forum that brings together senior executives and business development professionals from leading pharmaceutical and biotech companies.
Confirmed speakers will include:
- Karen Bernstein, BioCentury
- Martin Birkhofer, Bristol-Myers Squibb
- Dan Burgess, Rempex Pharmaceuticals
- Luke Evnin, MPM Capital
- Jennifer Friel Goldstein, Pfizer Venture Investments
- George Golumbeski, Celgene Corporation
- Faheem Hasnain, Receptos
- Natasha Hernday, Seattle Genetics
- Paul Laikind, Sanford Burnham Research Institute
- Patrick Mahaffy, Clovis Oncology
- Brian McVeigh, GlaxoSmithKline Pharmaceuticals
- Bob More, Frazier Healthcare
- Polly Murphy, Pfizer Inc.
- Mark Noguchi, Roche
- Melinda Richter, Prescience International
- Tony Rosenberg, Novartis
- Jim Schaeffer, Merck Research Laboratories
- Laura Shawver, Cleave BioSciences
- Andy Schwab, 5AM Ventures
- Philippe Tinmouth, Vertex Pharmaceuticals, Inc
- Kurt von Emster, venBio LLC
Register online today!
Shaye Exner
shaye.exner@biocom.org |
|
| |
 |
March 5–6, 2012
Dan Carmel, Haifa, Israel |
BioInvest Israel™ 2012 is the international gathering of the investment and corporate communities with the Israeli life sciences industry.
Organized in response to the growing demand for an efficient healthcare partnering forum where investors, medtech and biopharma companies can meet to talk business, BioInvest Israel 2012 provides private and public medtech and biopharma companies the opportunity to present and partner with an audience of investors and business development executives from Israel and abroad.
In today's challenging market the Israeli biomedical industry is becoming ever more attractive to global companies and investors looking for: creative finance, M&A deals, investments, deal flow of opportunities, intellectual property trade, IPs or exit opportunities that will increase the value of their firms.
Join us at BioInvest Israel and learn about the innovative investing opportunities awaiting you in Israel.
Sigal Weisswasser
sigal@thetbngroup.com |
|
| |
 |
April 24–26, 2012 |
BioTrinity is Europe’s Premier Biopartnering and Investment Conference which brings together a critical mass of active investors, global pharma and innovative biotech and medtech companies. Deploying EBD Group's partneringONE®, the industry gold-standard partnering system, BioTrinity hosts all of your meetings in private rooms and booths.
- Meet a hand-picked crop of early-stage companies you haven't seen elsewhere
- Meet active VC and corporate venture firms
- Meet the key licensing contacts from big pharma
- Meet the senior execs who can complete the value chain for your business
Register before 14 February and save GBP 50 with the Early Bird rate. Be a part of this must attend event!
Stephen Barton
+44 845 5049 720
stephen.barton@obn.org.uk |
| |
|
|
|
|
| |
|
 |
|
"I am delighted to report that our delegates set up hundreds of meetings through partneringONE, even though most of them were novice users. Thank you EBD Group for all your support in helping us start and market our new event. We look forward to working with you again."
President & CEO, The T.B.N. Group, organizers of IsraMedTech 2011
"Multisector collaborations are needed to turn a scientific discovery into an accessible therapy. The partneringONE system EBD Group has developed to meet the unique needs of all the sectors represented at Partnering for Cures is an important tool for facilitating collaborations necessary to expedite cures."
Executive Director of FasterCures, organizers of Partnering for Cures
"The partnering system was excellent. Coupled to the ability to meet senior BD&L and M&A people from big pharma, this event was an unprecedented success for Prosonix."
CEO, Prosonix, delegate at BioTrinity, UK
“Launching Biofit, a new event in the life science field, was a real challenge for our organization. We needed the best partnering tool, recognized worldwide and easy to use. It rapidly became obvious that partneringONE was the best choice.”
Managing Director, IDIS, organizer of Biofit, the Science to Market conference
|
|
|
 |
|
